• Update on bb2121, Potential Advanced Multiple Myeloma Therapy, Set for ASCO 2018
  • Recruitment Open for Phase 2 Trial Aimed at Complete Eradication of Myeloma Cells
  • FDA Names Cancer Vaccine Galinpepimut-S Orphan Drug as Possible Multiple Myeloma Treatment
  • FDA Approves Darzalex Combo Therapy for Certain Newly Diagnosed Patients
  • Selinexor May Bring Hope to Heavily Treated Myeloma Patients, Trial Results Show
  • 9/11 Firefighters at Greater Risk of Multiple Myeloma Precursor, Study Reports
  • Stand Up to Cancer Awards $10 Million to ‘Dream Team’ Focused on Early Detection of Precursor Multiple Myeloma Conditions
  • Chip-based Blood Test Might Replace Bone Marrow Biopsies for Myeloma, Scientists Say
  • Phase 1 Trial for Investigational Therapy STRO-001 Treats First Myeloma, Lymphoma Patients
  • New Method of Classifying Malignant Myeloma Cells Improves Outcomes, Study Finds
  • P-BCMA-101 Shows Early Effectiveness in First Multiple Myeloma Patients Treated in Phase 1 Trial
  • Seattle Genetics’ Investigational Therapy Fares Well in Multiple Myeloma Animal Models